These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24054146)

  • 1. The enduring centrality of dopamine in the pathophysiology of schizophrenia: in vivo evidence from the prodrome to the first psychotic episode.
    Bonoldi I; Howes OD
    Adv Pharmacol; 2013; 68():199-220. PubMed ID: 24054146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments.
    Howes OD; Fusar-Poli P; Bloomfield M; Selvaraj S; McGuire P
    Curr Pharm Des; 2012; 18(4):459-65. PubMed ID: 22239576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.
    Howes OD; McCutcheon R; Owen MJ; Murray RM
    Biol Psychiatry; 2017 Jan; 81(1):9-20. PubMed ID: 27720198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience.
    Kesby JP; Eyles DW; McGrath JJ; Scott JG
    Transl Psychiatry; 2018 Jan; 8(1):30. PubMed ID: 29382821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do psychosis prodrome onset negative symptoms predict first presentation negative symptoms?
    Lyne J; Renwick L; Madigan K; O'Donoghue B; Bonar M; Grant T; Kinsella A; Malone K; Turner N; O'Callaghan E; Clarke M
    Eur Psychiatry; 2014 Mar; 29(3):153-9. PubMed ID: 23523737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.
    Howes OD; Egerton A; Allan V; McGuire P; Stokes P; Kapur S
    Curr Pharm Des; 2009; 15(22):2550-9. PubMed ID: 19689327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognition in schizophrenia: from prodrome to multi-episode illness.
    Corigliano V; De Carolis A; Trovini G; Dehning J; Di Pietro S; Curto M; Donato N; De Pisa E; Girardi P; Comparelli A
    Psychiatry Res; 2014 Dec; 220(1-2):129-34. PubMed ID: 25149131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stress and psychotic transition: A literature review].
    Chaumette B; Kebir O; Mam Lam Fook C; Bourgin J; Godsil BP; Gaillard R; Jay TM; Krebs MO
    Encephale; 2016 Aug; 42(4):367-73. PubMed ID: 27161263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis.
    de la Fuente-Sandoval C; León-Ortiz P; Favila R; Stephano S; Mamo D; Ramírez-Bermúdez J; Graff-Guerrero A
    Neuropsychopharmacology; 2011 Aug; 36(9):1781-91. PubMed ID: 21508933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic dopaminergic function: implications for understanding treatment response in psychosis.
    Bonoldi I; Howes OD
    CNS Drugs; 2014 Jul; 28(7):649-63. PubMed ID: 24919790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study.
    Fusar-Poli P; Howes OD; Allen P; Broome M; Valli I; Asselin MC; Grasby PM; McGuire PK
    Arch Gen Psychiatry; 2010 Jul; 67(7):683-91. PubMed ID: 20603449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms.
    McCutcheon RA; Abi-Dargham A; Howes OD
    Trends Neurosci; 2019 Mar; 42(3):205-220. PubMed ID: 30621912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.
    Schifani C; Tseng HH; Kenk M; Tagore A; Kiang M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Brain; 2018 Jul; 141(7):2213-2224. PubMed ID: 29860329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salience and dysregulation of the dopaminergic system.
    Lahera G; Freund N; Sáiz-Ruiz J
    Rev Psiquiatr Salud Ment; 2013; 6(1):45-51. PubMed ID: 23084802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boredom, dopamine, and the thrill of psychosis: psychiatry in a new key.
    Branković S
    Psychiatr Danub; 2015 Jun; 27(2):126-37. PubMed ID: 26057307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms.
    Avram M; Brandl F; Cabello J; Leucht C; Scherr M; Mustafa M; Leucht S; Ziegler S; Sorg C
    Brain; 2019 Jun; 142(6):1813-1826. PubMed ID: 31135051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis.
    Howes OD; Montgomery AJ; Asselin MC; Murray RM; Grasby PM; McGuire PK
    Br J Psychiatry Suppl; 2007 Dec; 51():s13-8. PubMed ID: 18055930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia: the role of sleep and circadian rhythms in regulating dopamine and psychosis.
    Yates NJ
    Rev Neurosci; 2016 Oct; 27(7):669-687. PubMed ID: 27343471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping prodromal psychosis: a critical review of neuroimaging studies.
    Fusar-Poli P; McGuire P; Borgwardt S
    Eur Psychiatry; 2012 Apr; 27(3):181-91. PubMed ID: 21940151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate.
    Stahl SM
    CNS Spectr; 2018 Jun; 23(3):187-191. PubMed ID: 29954475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.